DOPAMINE UPTAKE - A REVIEW OF PROGRESS IN THE LAST DECADE

[1] MONOAMINE UPTAKE INTO SYNAPTOSOMES FROM VARIOUS REGIONS OF RAT-BRAIN FOLLOWING LITHIUM ADMINISTRATION AND WITHDRAWAL [J]. NEUROPHARMACOLOGY, 1981, 20 (05) : 483 - 487

[2] UPTAKE OF TAURINE, GABA, 5-HT, AND DOPAMINE BY BLOOD-PLATELETS IN PROGRESSIVE MYOCLONUS EPILEPSY [J]. EPILEPSIA, 1979, 20 (05) : 503 - 510

[3] AIRAKSINEN MM, 1980, ACTA PHARMACOL TOX, V46, P308

[4] DETECTION OF NEURONAL UPTAKE OF [H-3]DOPAMINE IN THE RABBIT CELIAC ARTERY [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 88 (2-3) : 251 - 254

[5] AMINOFF MJ, 1974, LANCET, V2, P1115

[6] BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF [H-3] GBR-12935 BINDING INVITRO TO RAT STRIATAL MEMBRANES - LABELING OF THE DOPAMINE UPTAKE COMPLEX [J]. JOURNAL OF NEUROCHEMISTRY, 1987, 48 (06) : 1887 - 1896

[7] THE DOPAMINE UPTAKE INHIBITOR GBR 12909 - SELECTIVITY AND MOLECULAR MECHANISM OF ACTION [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) : 493 - 504

[8] DIFFERENCES IN THE KINETICS OF DOPAMINE UPTAKE IN SYNAPTOSOME PREPARATIONS OF THE MEDIAN-EMINENCE RELATIVE TO OTHER DOPAMINERGICALLY INERVATED BRAIN-REGIONS [J]. NEUROENDOCRINOLOGY, 1980, 31 (05) : 316 - 320

[9] INVIVO EVALUATION OF STRIATAL DOPAMINE REUPTAKE SITES USING C-11 NOMIFENSINE AND POSITRON EMISSION TOMOGRAPHY [J]. ACTA NEUROLOGICA SCANDINAVICA, 1987, 76 (04): : 283 - 287

[10] ARY TE, 1980, LIFE SCI, V26, P575, DOI 10.1016/0024-3205(80)90322-7

[1] MONOAMINE UPTAKE INTO SYNAPTOSOMES FROM VARIOUS REGIONS OF RAT-BRAIN FOLLOWING LITHIUM ADMINISTRATION AND WITHDRAWAL [J]. NEUROPHARMACOLOGY, 1981, 20 (05) : 483 - 487

[2] UPTAKE OF TAURINE, GABA, 5-HT, AND DOPAMINE BY BLOOD-PLATELETS IN PROGRESSIVE MYOCLONUS EPILEPSY [J]. EPILEPSIA, 1979, 20 (05) : 503 - 510

[3] AIRAKSINEN MM, 1980, ACTA PHARMACOL TOX, V46, P308

[4] DETECTION OF NEURONAL UPTAKE OF [H-3]DOPAMINE IN THE RABBIT CELIAC ARTERY [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 88 (2-3) : 251 - 254

[5] AMINOFF MJ, 1974, LANCET, V2, P1115

[6] BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF [H-3] GBR-12935 BINDING INVITRO TO RAT STRIATAL MEMBRANES - LABELING OF THE DOPAMINE UPTAKE COMPLEX [J]. JOURNAL OF NEUROCHEMISTRY, 1987, 48 (06) : 1887 - 1896

[7] THE DOPAMINE UPTAKE INHIBITOR GBR 12909 - SELECTIVITY AND MOLECULAR MECHANISM OF ACTION [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 166 (03) : 493 - 504

[8] DIFFERENCES IN THE KINETICS OF DOPAMINE UPTAKE IN SYNAPTOSOME PREPARATIONS OF THE MEDIAN-EMINENCE RELATIVE TO OTHER DOPAMINERGICALLY INERVATED BRAIN-REGIONS [J]. NEUROENDOCRINOLOGY, 1980, 31 (05) : 316 - 320

[9] INVIVO EVALUATION OF STRIATAL DOPAMINE REUPTAKE SITES USING C-11 NOMIFENSINE AND POSITRON EMISSION TOMOGRAPHY [J]. ACTA NEUROLOGICA SCANDINAVICA, 1987, 76 (04): : 283 - 287

[10] ARY TE, 1980, LIFE SCI, V26, P575, DOI 10.1016/0024-3205(80)90322-7